Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 22607-22608 [2010-9952]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 82 / Thursday, April 29, 2010 / Notices
Special Minority Initiatives, National
Institutes of Health, HHS)
Dated: April 23, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–9987 Filed 4–28–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of
Meetings
mstockstill on DSKH9S0YB1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of meetings of the National
Advisory Neurological Disorders and
Stroke Council.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council,
Clinical Trials Subcommittee.
Date: May 26–27, 2010.
Closed: May 26, 2010, 6:30 p.m. to 8 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Open: May 27, 2010, 8 a.m. to 9:30 a.m.
Agenda: To discuss clinical trials policy.
Place: National Institutes of Health,
Building 31, 31 Center Drive, 6th Floor,
Conference Room 10, Bethesda, MD 20892.
Contact Person: Petra Kaufmann, MD,
Director, Office of Clinical Research, NINDS,
National Institutes of Health, Neuroscience
Center, Room 2216, 6001 Executive Blvd.
(301) 496–9135. Kaufmanp2@ninds.nih.gov.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council,
Basic and Preclinical Programs
Subcommittee.
VerDate Mar<15>2010
16:19 Apr 28, 2010
Jkt 220001
Date: May 27, 2010.
Time: 8 a.m. to 9:30 a.m.
Agenda: To discuss basic and preclinical
policy.
Place: National Institutes of Health,
Building 31, 31 Center Drive, 6th Floor,
Conference Room 7, Bethesda, MD 20892.
Contact Person: William D. Matthew, PhD,
Director, Office of Translational Research,
NINDS, National Institutes of Health,
Neuroscience Center, Room 2137, 6001
Executive Blvd. (301) 496–1779.
Bill.Matthew@nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.ninds.nih.gov, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: April 23, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–9986 Filed 4–28–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
Coordinating Center for Infectious
Diseases (CCID)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the cancellation of the May
2010 meeting of the aforementioned
board. Due to unanticipated
circumstances and scheduling conflicts,
the board does not have the quorum
required to convene.
Contact Person for More Information:
Leola Mitchell, Office of the Director,
CCID, CDC, 1600 Clifton Road, NE.,
Mailstop K–74, Atlanta, Georgia 30333,
e-mail fvp9@cdc.gov, telephone (770)
488–8366.
The Director, Management Analysis
and Services Office has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
22607
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: April 21 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2010–9953 Filed 4–28–10; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or Advisory
Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), and pursuant to the
requirements of 42 CFR 83.15(a), the
Centers for Disease Control and
Prevention (CDC), announces the
following meeting of the
aforementioned committee:
Board Public Meeting Times and Dates (All
times are Eastern Time)
8:15 a.m.–4:30 p.m., May 19, 2010.
8:15 a.m.–6 p.m., May 20, 2010.
8:15 a.m.–12 p.m., May 21, 2010.
Public Comment Times and Dates (All times
are Eastern Time)
4:30 p.m.–6 p.m.,* May 19, 2010.
6 p.m.–7:30 p.m.,* May 20, 2010.
*Please note that the public comment
periods may end before the times indicated,
following the last call for comments.
Members of the public who wish to provide
public comment should plan to attend public
comment sessions at the start times listed.
Place: Crowne Plaza Hotel, 300 3rd Street,
Niagara Falls, New York; Phone: 716–285–
3361; Fax: 716–285–3900. Audio Conference
Call via FTS Conferencing. The USA toll free
dial in number is 1–866–659–0537 with a
pass code of 9933701.
Status: Open to the public, limited only by
the space available. The meeting space
accommodates approximately 200 people.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation Program
(EEOICP) Act of 2000 to advise the President
on a variety of policy and technical functions
required to implement and effectively
manage the new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines which
have been promulgated by the Department of
Health and Human Services (HHS) as a final
rule, advice on methods of dose
reconstruction which have also been
E:\FR\FM\29APN1.SGM
29APN1
mstockstill on DSKH9S0YB1PROD with NOTICES
22608
Federal Register / Vol. 75, No. 82 / Thursday, April 29, 2010 / Notices
promulgated by HHS as a final rule, advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program, and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to the
CDC. NIOSH implements this responsibility
for CDC. The charter was issued on August
3, 2001, renewed at appropriate intervals,
and will expire on August 3, 2011.
Purpose: This Advisory Board is charged
with (a) Providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b) providing
advice to the Secretary, HHS, on the
scientific validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at any
Department of Energy facility who were
exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and
on whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of this
class.
Matters to be Discussed: The agenda for the
Advisory Board meeting includes: NIOSH
Program Update and Program Evaluation
Plans; Department of Labor (DOL) Program
Update; Department of Energy (DOE)
Program Update; Board Surrogate Data
Criteria; Special Exposure Cohort (SEC)
petitions for: Mound Plant, Hooker
Electrochemical (Niagara Falls, New York),
Linde Ceramics Plant (Tonawanda, New
York), St. Louis Airport Storage Site, Weldon
Spring Plant (St. Louis, Missouri), Blockson
Chemical Company, Chapman Valve
Manufacturing Company, Los Alamos
National Laboratory, Bethlehem Steel
Company (Lackawanna, New York), De Soto
Avenue Facility (Los Angeles County, CA),
Downey Facility (Los Angeles County, CA),
University of Rochester Atomic Energy
Project, BWX Technologies (Lynchburg, VA);
SEC Petition Status Updates; Subcommittee
and Work Group Reports; and Board Working
Time.
The agenda is subject to change as
priorities dictate.
In the event an individual cannot attend,
written comments may be submitted in
accordance with the redaction policy
provided below. Any written comments
received will be provided at the meeting and
should be submitted to the contact person
below well in advance of the meeting.
Policy on Redaction of Board Meeting
Transcripts (Public Comment), (1) If a person
making a comment gives his or her name, no
attempt will be made to redact that name. (2)
NIOSH will take reasonable steps to ensure
that individuals making public comment are
aware of the fact that their comments
(including their name, if provided) will
appear in a transcript of the meeting posted
on a public Web site. Such reasonable steps
include: (a) A statement read at the start of
each public comment period stating that
VerDate Mar<15>2010
16:19 Apr 28, 2010
Jkt 220001
transcripts will be posted and names of
speakers will not be redacted; (b) A printed
copy of the statement mentioned in (a) above
will be displayed on the table where
individuals sign up to make public comment;
(c) A statement such as outlined in (a) above
will also appear with the agenda for a Board
Meeting when it is posted on the NIOSH Web
site; (d) A statement such as in (a) above will
appear in the Federal Register Notice that
announces Board and Subcommittee
meetings. (3) If an individual in making a
statement reveals personal information (e.g.,
medical information) about themselves that
information will not usually be redacted. The
NIOSH FOIA coordinator will, however,
review such revelations in accordance with
the Freedom of Information Act and the
Federal Advisory Committee Act and if
deemed appropriate, will redact such
information. (4) All disclosures of
information concerning third parties will be
redacted. (5) If it comes to the attention of the
Designated Federal Officer (DFO) that an
individual wishes to share information with
the Board but objects to doing so in a public
forum, the DFO will work with that
individual, in accordance with the Federal
Advisory Committee Act, to find a way that
the Board can hear such comments.
Contact Person for More Information:
Theodore Katz, M.P.A., Executive Secretary,
NIOSH, CDC, 1600 Clifton Road, MS E–20,
Atlanta, GA 30333, Telephone (513) 33–6800,
Toll Free 1 (800) CDC–INFO, E-mail
ocas@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register Notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: April 21, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2010–9952 Filed 4–28–10; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Part D Comprehensive Services and
Access to Research for Women,
Infants, Children and Youth Grant
Under the Ryan White HIV/AIDS
Program
AGENCY: Health Resources and Services
Administration (HRSA), HHS.
ACTION: Notice of Non-Competitive Part
D Award Funds for the Mecklenburg
County Health Department and Duke
University.
SUMMARY: HRSA will be awarding noncompetitive Part D funds to the
Mecklenburg County Health Department
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
in order to ensure continuity of critical
HIV medical care and treatment
services, and to avoid a disruption of
HIV clinical care and support services to
women, infants, children, and youth in
the Charlotte, North Carolina and
surrounding counties. HRSA will also
be awarding non-competitive Part D
Funds to Duke University in order to
ensure continuity of critical HIV
medical care and treatment services,
and to avoid a disruption of HIV clinical
care and support services to women,
infants, children, and youth in the
central North Carolina area.
SUPPLEMENTARY INFORMATION:
Grantee of record: Metrolina AIDS
Project.
Intended recipients of the award:
Mecklenburg County Health
Department, Charlotte, North Carolina
and Duke University, Durham, North
Carolina.
Amount of the award: To each
recipient, $239,136 (initial 6-month
award) and $431,680 (anticipated 12month award) to ensure ongoing HIV
clinical and support services to the
target population.
Authority: Section 2671 of the Public
Health Service Act, 42 U.S.C. 300ff–51.
CFDA Number: 93.918.
Project period: February 1, 2010 to
July 31, 2011. The period of support for
this award is from February 1, 2010 to
July 31, 2011.
Justification for the Exception to
Competition
Funding for critical HIV medical care,
treatment, and support services to
women, infants, children, and youth in
the Charlotte, North Carolina and
central North Carolina areas, will be
continued through non-competitive
awards to the Mecklenburg County
Health Department and Duke
University, respectively, as each has the
fiscal and administrative infrastructure
to administer the Part D Grant. These
are temporary replacement awards. The
previous grant recipient serving this
population notified HRSA that it was
closing and could not continue
providing Part D services after January
31, 2010. This recipient served two
distinct service areas with its Part D
Grant, and no other entity has the
capacity to serve both areas. HRSA’s
HIV/AIDS Bureau identified the
Mecklenburg County Health Department
and Duke University as the best
qualified Grantees for these awards. The
Mecklenburg County Health Department
is also the Part A Grant administrator
that ensures accessibility to health care
services for these clients. Duke
University was the primary contractor
E:\FR\FM\29APN1.SGM
29APN1
]]>Agencies
[Federal Register Volume 75, Number 82 (Thursday, April 29, 2010)]
[Notices]
[Pages 22607-22608]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-9952]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH or Advisory
Board), National Institute for Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), and pursuant to the requirements of 42
CFR 83.15(a), the Centers for Disease Control and Prevention (CDC),
announces the following meeting of the aforementioned committee:
Board Public Meeting Times and Dates (All times are Eastern Time)
8:15 a.m.-4:30 p.m., May 19, 2010.
8:15 a.m.-6 p.m., May 20, 2010.
8:15 a.m.-12 p.m., May 21, 2010.
Public Comment Times and Dates (All times are Eastern Time)
4:30 p.m.-6 p.m.,* May 19, 2010.
6 p.m.-7:30 p.m.,* May 20, 2010.
*Please note that the public comment periods may end before the
times indicated, following the last call for comments. Members of
the public who wish to provide public comment should plan to attend
public comment sessions at the start times listed.
Place: Crowne Plaza Hotel, 300 3rd Street, Niagara Falls, New
York; Phone: 716-285-3361; Fax: 716-285-3900. Audio Conference Call
via FTS Conferencing. The USA toll free dial in number is 1-866-659-
0537 with a pass code of 9933701.
Status: Open to the public, limited only by the space available.
The meeting space accommodates approximately 200 people.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program (EEOICP) Act of
2000 to advise the President on a variety of policy and technical
functions required to implement and effectively manage the new
compensation program. Key functions of the Advisory Board include
providing advice on the development of probability of causation
guidelines which have been promulgated by the Department of Health
and Human Services (HHS) as a final rule, advice on methods of dose
reconstruction which have also been
[[Page 22608]]
promulgated by HHS as a final rule, advice on the scientific
validity and quality of dose estimation and reconstruction efforts
being performed for purposes of the compensation program, and advice
on petitions to add classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to the CDC. NIOSH implements
this responsibility for CDC. The charter was issued on August 3,
2001, renewed at appropriate intervals, and will expire on August 3,
2011.
Purpose: This Advisory Board is charged with (a) Providing
advice to the Secretary, HHS, on the development of guidelines under
Executive Order 13179; (b) providing advice to the Secretary, HHS,
on the scientific validity and quality of dose reconstruction
efforts performed for this program; and (c) upon request by the
Secretary, HHS, advise the Secretary on whether there is a class of
employees at any Department of Energy facility who were exposed to
radiation but for whom it is not feasible to estimate their
radiation dose, and on whether there is reasonable likelihood that
such radiation doses may have endangered the health of members of
this class.
Matters to be Discussed: The agenda for the Advisory Board
meeting includes: NIOSH Program Update and Program Evaluation Plans;
Department of Labor (DOL) Program Update; Department of Energy (DOE)
Program Update; Board Surrogate Data Criteria; Special Exposure
Cohort (SEC) petitions for: Mound Plant, Hooker Electrochemical
(Niagara Falls, New York), Linde Ceramics Plant (Tonawanda, New
York), St. Louis Airport Storage Site, Weldon Spring Plant (St.
Louis, Missouri), Blockson Chemical Company, Chapman Valve
Manufacturing Company, Los Alamos National Laboratory, Bethlehem
Steel Company (Lackawanna, New York), De Soto Avenue Facility (Los
Angeles County, CA), Downey Facility (Los Angeles County, CA),
University of Rochester Atomic Energy Project, BWX Technologies
(Lynchburg, VA); SEC Petition Status Updates; Subcommittee and Work
Group Reports; and Board Working Time.
The agenda is subject to change as priorities dictate.
In the event an individual cannot attend, written comments may
be submitted in accordance with the redaction policy provided below.
Any written comments received will be provided at the meeting and
should be submitted to the contact person below well in advance of
the meeting.
Policy on Redaction of Board Meeting Transcripts (Public
Comment), (1) If a person making a comment gives his or her name, no
attempt will be made to redact that name. (2) NIOSH will take
reasonable steps to ensure that individuals making public comment
are aware of the fact that their comments (including their name, if
provided) will appear in a transcript of the meeting posted on a
public Web site. Such reasonable steps include: (a) A statement read
at the start of each public comment period stating that transcripts
will be posted and names of speakers will not be redacted; (b) A
printed copy of the statement mentioned in (a) above will be
displayed on the table where individuals sign up to make public
comment; (c) A statement such as outlined in (a) above will also
appear with the agenda for a Board Meeting when it is posted on the
NIOSH Web site; (d) A statement such as in (a) above will appear in
the Federal Register Notice that announces Board and Subcommittee
meetings. (3) If an individual in making a statement reveals
personal information (e.g., medical information) about themselves
that information will not usually be redacted. The NIOSH FOIA
coordinator will, however, review such revelations in accordance
with the Freedom of Information Act and the Federal Advisory
Committee Act and if deemed appropriate, will redact such
information. (4) All disclosures of information concerning third
parties will be redacted. (5) If it comes to the attention of the
Designated Federal Officer (DFO) that an individual wishes to share
information with the Board but objects to doing so in a public
forum, the DFO will work with that individual, in accordance with
the Federal Advisory Committee Act, to find a way that the Board can
hear such comments.
Contact Person for More Information: Theodore Katz, M.P.A.,
Executive Secretary, NIOSH, CDC, 1600 Clifton Road, MS E-20,
Atlanta, GA 30333, Telephone (513) 33-6800, Toll Free 1 (800) CDC-
INFO, E-mail ocas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: April 21, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2010-9952 Filed 4-28-10; 8:45 am]
BILLING CODE 4163-18-P
